These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9479827)

  • 1. Roles of cyclin-dependent kinase inhibitors: lessons from knockout mice.
    Kiyokawa H; Koff A
    Curr Top Microbiol Immunol; 1998; 227():105-20. PubMed ID: 9479827
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
    Chellappan SP; Giordano A; Fisher PB
    Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826
    [No Abstract]   [Full Text] [Related]  

  • 3. CDK inhibitors: positive and negative regulators of G1-phase progression.
    Sherr CJ; Roberts JM
    Genes Dev; 1999 Jun; 13(12):1501-12. PubMed ID: 10385618
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitors of the Cip/Kip family.
    Hengst L; Reed SI
    Curr Top Microbiol Immunol; 1998; 227():25-41. PubMed ID: 9479824
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.
    Watanabe G; Pena P; Shambaugh GE; Haines GK; Pestell RG
    Brain Res Dev Brain Res; 1998 Jun; 108(1-2):77-87. PubMed ID: 9693786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eNOS inhibition of proliferation: a role for p21(Sdi1/Cip1/Waf1) and p27(kip1).
    Holt CM
    Cardiovasc Res; 2000 Sep; 47(4):640-1. PubMed ID: 10974212
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
    Swanton C; Mann DJ; Fleckenstein B; Neipel F; Peters G; Jones N
    Nature; 1997 Nov; 390(6656):184-7. PubMed ID: 9367157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation.
    Tian JQ; Quaroni A
    Am J Physiol; 1999 Jun; 276(6):C1245-58. PubMed ID: 10362586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas.
    Saegusa M; Machida B D; Okayasu I
    Cancer; 2001 Sep; 92(5):1177-89. PubMed ID: 11571731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase inhibitors--a novel class of prognostic indicators.
    Palazzo JP
    Hum Pathol; 2001 Aug; 32(8):769-70. PubMed ID: 11521217
    [No Abstract]   [Full Text] [Related]  

  • 18. [Regulation of the cell cycle--involvement of protein inhibitors of cyclin-dependent kinases].
    Grzelakowska-Sztabert B
    Postepy Biochem; 1995; 41(2):80-93. PubMed ID: 7479444
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
    Ragione FD; Iolascon A
    Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.